Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study
Xuexue Bai,1 Xiaomin Liu,2 Jun Wen1 1Neurosurgery, The First Affiliated Hospital, Jinan University, Guangzhou, People’s Republic of China; 2Neurosurgery, Tianjin Huanhu Hospital, Tianjin, People’s Republic of ChinaCorrespondence: Xiaomin Liu; Jun Wen, Email liuxiaomin619@163.com; willwenjun0905@163....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-08-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Subjects: | |
| Online Access: | https://www.dovepress.com/efficacy-of-bevacizumab-in-high-grade-meningiomas-a-retrospective-clin-peer-reviewed-fulltext-article-NDT |
| _version_ | 1811342716511977472 |
|---|---|
| author | Bai X Liu X Wen J |
| author_facet | Bai X Liu X Wen J |
| author_sort | Bai X |
| collection | DOAJ |
| description | Xuexue Bai,1 Xiaomin Liu,2 Jun Wen1 1Neurosurgery, The First Affiliated Hospital, Jinan University, Guangzhou, People’s Republic of China; 2Neurosurgery, Tianjin Huanhu Hospital, Tianjin, People’s Republic of ChinaCorrespondence: Xiaomin Liu; Jun Wen, Email liuxiaomin619@163.com; willwenjun0905@163.comObjective: We investigated the role of bevacizumab (BV) in high-grade meningiomas (HGMs) by retrospective analysis.Methods: We retrospectively analyzed the clinical data of 139 patients with HGMs. The chi-square test was used to compare progression-free survival (PFS) and overall survival (OS) between patients who received BV and those who did not. According to whether they received BV treatment, we divided the patients into the BV group and non-BV group, and the effect of BV on PFS and OS was compared. In addition, we compared Karnofsky performance status (KPS) and steroid doses between the BV and non-BV groups.Results: There were statistically differences in PFS and OS between the BV and non-BV groups at 12 and 36 months after surgery (P< 0.05). However, there was no significant difference in PFS and OS between the two groups at 60 months postoperatively (P> 0.05). Using survival curves drawn by the Kaplan Meier method, we found that the PFS and OS of the BV group were greater than those of the non-BV group, and the difference was statistically significant (P< 0.05).Conclusion: BV could improve PFS and OS at 12 and 36 months after surgery in patients with HGMs. In addition, BV was associated with lower preoperative steroid use.Keywords: bevacizumab, meningiomas, peritumoral brain edema, progression-free survival, overall survival |
| first_indexed | 2024-04-13T19:15:41Z |
| format | Article |
| id | doaj.art-864652e5641e45eb8e1399665893336b |
| institution | Directory Open Access Journal |
| issn | 1178-2021 |
| language | English |
| last_indexed | 2024-04-13T19:15:41Z |
| publishDate | 2022-08-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Neuropsychiatric Disease and Treatment |
| spelling | doaj.art-864652e5641e45eb8e1399665893336b2022-12-22T02:33:41ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212022-08-01Volume 181619162777154Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical StudyBai XLiu XWen JXuexue Bai,1 Xiaomin Liu,2 Jun Wen1 1Neurosurgery, The First Affiliated Hospital, Jinan University, Guangzhou, People’s Republic of China; 2Neurosurgery, Tianjin Huanhu Hospital, Tianjin, People’s Republic of ChinaCorrespondence: Xiaomin Liu; Jun Wen, Email liuxiaomin619@163.com; willwenjun0905@163.comObjective: We investigated the role of bevacizumab (BV) in high-grade meningiomas (HGMs) by retrospective analysis.Methods: We retrospectively analyzed the clinical data of 139 patients with HGMs. The chi-square test was used to compare progression-free survival (PFS) and overall survival (OS) between patients who received BV and those who did not. According to whether they received BV treatment, we divided the patients into the BV group and non-BV group, and the effect of BV on PFS and OS was compared. In addition, we compared Karnofsky performance status (KPS) and steroid doses between the BV and non-BV groups.Results: There were statistically differences in PFS and OS between the BV and non-BV groups at 12 and 36 months after surgery (P< 0.05). However, there was no significant difference in PFS and OS between the two groups at 60 months postoperatively (P> 0.05). Using survival curves drawn by the Kaplan Meier method, we found that the PFS and OS of the BV group were greater than those of the non-BV group, and the difference was statistically significant (P< 0.05).Conclusion: BV could improve PFS and OS at 12 and 36 months after surgery in patients with HGMs. In addition, BV was associated with lower preoperative steroid use.Keywords: bevacizumab, meningiomas, peritumoral brain edema, progression-free survival, overall survivalhttps://www.dovepress.com/efficacy-of-bevacizumab-in-high-grade-meningiomas-a-retrospective-clin-peer-reviewed-fulltext-article-NDTbevacizumabmeningiomasperitumoral brain edemaprogression-free survivaloverall survival |
| spellingShingle | Bai X Liu X Wen J Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study Neuropsychiatric Disease and Treatment bevacizumab meningiomas peritumoral brain edema progression-free survival overall survival |
| title | Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study |
| title_full | Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study |
| title_fullStr | Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study |
| title_full_unstemmed | Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study |
| title_short | Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study |
| title_sort | efficacy of bevacizumab in high grade meningiomas a retrospective clinical study |
| topic | bevacizumab meningiomas peritumoral brain edema progression-free survival overall survival |
| url | https://www.dovepress.com/efficacy-of-bevacizumab-in-high-grade-meningiomas-a-retrospective-clin-peer-reviewed-fulltext-article-NDT |
| work_keys_str_mv | AT baix efficacyofbevacizumabinhighgrademeningiomasaretrospectiveclinicalstudy AT liux efficacyofbevacizumabinhighgrademeningiomasaretrospectiveclinicalstudy AT wenj efficacyofbevacizumabinhighgrademeningiomasaretrospectiveclinicalstudy |